AI assistant
Sending…
RESMED INC — Director's Dealing 2013
Nov 15, 2013
30071_dirs_2013-11-15_4bbcc53a-1708-4bd6-bfce-9d88a5c56e94.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-11-13
Reporting Person: FARRELL PETER C (Director, Executive Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-13 | ResMed Common Stock | A | 4975 | — | Acquired | 489876 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 200000 | Indirect |
Footnotes
F1: Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2014 or the annual shareholder's meeting in the year following the grant date. Only 50% will distribute upon vesting; the remaining 50% require a holding period until the earlier of the third annual shareholder's meeting following the grant date or 6 months after termination of service.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29